Novel culture system of mesenchymal stromal cells from human subcutaneous adipose tissue

Stem Cells and Development

Volumn 18, Issue 4, 2009, Pages 533-543

  Iwashima, Shigejiro ^a   Ozaki, Takenori ^a   Maruyama, Shoichi ^a   Saka, Yousuke ^a   Kobori, Masato ^c   Omae, Kaoru ^d   Yamaguchi, Hirotake ^d   Niimi, Tomoaki ^e   Toriyama, Kazuhiro ^a   Kamei, Yuzuru ^a   Torii, Shuhei ^a   Murohara, Toyoaki ^b   Yuzawa, Yukio ^a   Kitagawa, Yasuo ^d,e   Matsuo, Seiichi ^a  

^a Department of Nephrology ^*  (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c KYOWA HAKKO KOGYO CO LTD   (Japan)

^d JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^e NAGOYA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE MARKER; FIBROBLAST GROWTH FACTOR 2; SCATTER FACTOR; VASCULOTROPIN; VASCULOTROPIN ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BLOOD FLOW; CAPILLARY DENSITY; CELL DIFFERENTIATION; CELL EXPANSION; CELL LINEAGE; CELL PROLIFERATION; CELL REGENERATION; CELL SECRETION; CELL THERAPY; CONTROLLED STUDY; CULTURE MEDIUM; CULTURE TECHNIQUE; ENDOTHELIUM CELL; FEMALE; HEMATOPOIETIC STEM CELL; HINDLIMB; HUMAN; HUMAN CELL; HUMAN TISSUE; LIMB ISCHEMIA; MALE; MESENCHYMAL STEM CELL; MESENCHYME CELL; NONHUMAN; NUDE RAT; PRIORITY JOURNAL; RAT; SERUM; STROMA CELL; SUBCUTANEOUS FAT;

ANIMALS; BIOLOGICAL MARKERS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL SHAPE; CHEMOKINE CXCL12; CULTURE MEDIA, CONDITIONED; CYTOKINES; HEPATOCYTE GROWTH FACTOR; HINDLIMB; HUMANS; ISCHEMIA; LASER-DOPPLER FLOWMETRY; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; RATS; RATS, INBRED F344; RATS, NUDE; STROMAL CELLS; SUBCUTANEOUS FAT; TISSUE THERAPY; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

RATTUS;

EID: 67649277717     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2008.0358     Document Type: Article

References (49)

1. Takahashi K, K Tanabe, M Ohnuki, M Narita, T Ichisaka, K Tomoda and S Yamanaka. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861-872.
2. Rafii S and D Lyden. (2003). Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 9:702-712.
3. Wobus AM and KR Boheler. (2005). Embryonic stem cells: prospects for developmental biology and cell therapy. Physiol Rev 85:635-678.
4. Perin EC, YJ Geng and JT Willerson. (2003). Adult stem cell therapy in perspective. Circulation 107:935-938.
5. Freedman SB and JM Isner. (2002). Therapeutic angiogenesis for coronary artery disease. Ann Intern Med 136:54-71.
6. Assmus B, V Schachinger, C Teupe, M Britten, R Lehmann, N Dobert, F Grunwald, A Aicher, C Urbich, H Martin, D Hoelzer, S Dimmeler and AM Zeiher. (2002). Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Circulation 106:3009-3017
7. Stamm C, B Westphal, HD Kleine, M Petzsch, C Kittner, H Klinge, C Schumichen, CA Nienaber, M Freund and G Steinhoff. (2003). Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 361:45-46.
8. Strauer BE, M Brehm, T Zeus, M Kostering, A Hernandez, RV Sorg, G Kogler and P Wernet. (2002). Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 106:1913-1918.
9. Wollert KC, GP Meyer, J Lotz, S Ringes-Lichtenberg, P Lippolt, C Breidenbach, S Fichtner, T Korte, B Hornig, D Messinger, L Arseniev, B Hertenstein, A Ganser and H Drexler. (2004). Intracoronary autologous bone-marrow cell transfer after myo- cardial infarction: the BOOST randomised controlled clinical trial. Lancet 364:141-148.
10. Tateishi-Yuyama E, H Matsubara, T Murohara, U Ikeda, S Shintani, H Masaki, K Amano, Y Kishimoto, K Yoshimoto, H Akashi, K Shimada, T Iwasaka and T Imaizumi. (2002). Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 360:427-435.
11. Lunde K, S Solheim, S Aakhus, H Arnesen, M Abdelnoor, T Egeland, Endresen, K, A Ilebekk, A Mangschau, JG Fjeld, HJ Smith, E Taraldsrud, HK Grogaard, R Bjornerheim, M Brekke, C Muller, E Hopp, A Ragnarsson, JE Brinchmann and K Forfang. (2006). Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med 355:1199-1209.
12. Rosenzweig A. (2006). Cardiac cell therapy-mixed results from mixed cells. N Engl J Med 355:1274-1277.
13. Mauney JR, V Volloch and DL Kaplan. (2005). Role of adult mes- enchymal stem cells in bone tissue engineering applications: current status and future prospects. Tissue Eng 11:787-802.
14. Pittenger MF and BJ Martin. (2004). Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res 95:9-20.
15. Kitoh H, T Kitakoji, H Tsuchiya, M Katoh and N Ishiguro. (2007). Transplantation of culture expanded bone marrow cells and platelet rich plasma in distraction osteogenesis of the long bones. Bone 40:522-528.
16. Phinney DG and DJ Prockop. (2007). Concise review: mesen- chymal stem/multipotent stromal cells: the state of transdiffer- entiation and modes of tissue repair-current views. Stem Cells 25:2896-2902.
17. Zuk PA, M Zhu, H Mizuno, J Huang, JW Futrell, AJ Katz, P Benhaim, HP Lorenz and MH Hedrick. (2001). Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7:211-228.
18. Fraser JK, I Wulur, Z Alfonso and MH Hedrick. (2006). Fat tissue: an underappreciated source of stem cells for biotechnology. Trends Biotechnol 24:150-154.
19. Strem BM and MH Hedrick. (2005). The growing importance of fat in regenerative medicine. Trends Biotechnol 23:64-66.
20. Schaffler A and C Buchler. (2007). Concise review: adipose tissue-derived stromal cells-basic and clinical implications for novel cell-based therapies. Stem Cells 25:818-827.
21. Pittenger MF, AM Mackay, SC Beck, RK Jaiswal, R Douglas, JD Mosca, MA Moorman, DW Simonetti, S Craig and DR Marshak. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147.
22. Bruder SP, N Jaiswal and SE Haynesworth. (1997). Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J Cell Biochem 64:278-294.
23. Mackay AM, SC Beck, JM Murphy, FP Barry, CO Chichester and MF Pittenger. (1998). Chondrogenic differentiation of cultured human mesenchymal stem cells from marrow. Tissue Eng 4:415-428.
24. Cory AH, TC Owen, JA Barltrop and JG Cory. (1991). Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture. Cancer Commun 3:207-212.
25. Hall JL, X Wang, A Van, Y Zhao and GH Gibbons. (2001). Overexpression of Ref-1 inhibits hypoxia and tumor necrosis factor-induced endothelial cell apoptosis through nuclear fac- tor-kappab-independent and -dependent pathways. Circ Res 88:1247-1253.
26. Ozaki T, C Anas, S Maruyama, T Yamamoto, K Yasuda, Y Morita, Y Ito, M Gotoh, Y Yuzawa and S Matsuo. (2008). Intrarenal administration of recombinant human soluble thrombomod- ulin ameliorates ischaemic acute renal failure. Nephrol Dial Transplant 23:110-119.
27. Taniyama Y, R Morishita, M Aoki, H Nakagami, K Yamamoto, K Yamazaki, K Matsumoto, T Nakamura, Y Kaneda and T Ogihara. (2001). Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial disease. Gene Ther 8:181-189.
28. I noue N, T Kondo, K Kobayashi, M Aoki, Y Numaguchi, M Shibuya and T Murohara. (2007). Therapeutic angiogenesis using novel vascular endothelial growth factor-E/human placental growth factor chimera genes. Arterioscler Thromb Vasc Biol 27:99-105.
29. Shimizu H, S Maruyama, Y Yuzawa, T Kato, Y Miki, S Suzuki, W Sato, Y Morita, H Maruyama, K Egashira and S Matsuo. (2003). Anti-monocyte chemoattractant protein-1 gene therapy attenuates renal injury induced by protein-overload proteinuria. J Am Soc Nephrol 14:1496-1505.
30. Suzuki S, S Maruyama, W Sato, Y Morita, F Sato, Y Miki, S Kato, M Katsuno, G Sobue, Y Yuzawa and S Matsuo. (2005). Geranylgeranylacetone ameliorates ischemic acute renal failure via induction of Hsp70. Kidney Int 67:2210-2220.
31. Wagner W, F Wein, A Seckinger, M Frankhauser, U Wirkner, U Krause, J Blake, C Schwager, V Eckstein, W Ansorge and AD Ho. (2005). Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Exp Hematol 33:1402-1416.
32. Zuk PA, M Zhu, P Ashjian, DA De Ugarte, JI Huang, H Mizuno, ZC Alfonso, JK Fraser, P Benhaim and MH Hedrick. (2002). Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13:4279-4295.
33. Cousin B, M Andre, E Arnaud, L Penicaud and L Casteilla. (2003). Reconstitution of lethally irradiated mice by cells isolated from adipose tissue. Biochem Biophys Res Commun 301:1016-1022.
34. Safford KM, KC Hicok, SD Safford, YD Halvorsen, WO Wilkison, JM Gimble and HE Rice. (2002). Neurogenic differentiation of murine and human adipose-derived stromal cells. Biochem Biophys Res Commun 294:371-379.
35. Kocaoemer A, S Kern, H Kluter and K Bieback. (2007). Human AB serum and thrombin-activated platelet-rich plasma are suitable alternatives to fetal calf serum for the expansion of mesen- chymal stem cells from adipose tissue. Stem Cells 25:1270-1278.
36. Parker AM, H Shang, M Khurgel and AJ Katz. (2007). Low serum and serum-free culture of multipotential human adipose stem cells. Cytotherapy 9:637-646.
37. Tsutsumi S, A Shimazu, K Miyazaki, H Pan, C Koike, E Yoshida, K Takagishi and Y Kato. (2001). Retention of multilineage differentiation potential of mesenchymal cells during proliferation in response to FGF. Biochem Biophys Res Commun 288:413-419.
38. Battula VL, PM Bareiss, S Treml, S Conrad, I Albert, S Hojak, H Abele, B Schewe, L Just, T Skutella and HJ Buhring. (2007). Human placenta and bone marrow derived MSC cultured in serum-free, b-FGF-containing medium express cell surface frizzled-9 and SSEA-4 and give rise to multilineage differentiation. Differentiation 75:279-291.
39. Sotiropoulou PA, SA Perez, M Salagianni, CN Baxevanis and M Papamichail. (2006). Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells. Stem Cells 24:462-471.
40. Ito T, R Sawada, Y Fujiwara, Y Seyama and T Tsuchiya. (2007). FGF-2 suppresses cellular senescence of human mesenchymal stem cells by down-regulation of TGF-beta2. Biochem Biophys Res Commun 359:108-114.
41. Akita S, K Akino, T Imaizumi and A Hirano. (2005). A basic fibroblast growth factor improved the quality of skin grafting in burn patients. Burns 31:855-858.
42. Katsube Y, M Hirose, C Nakamura and H Ohgushi. (2008). Correlation between proliferative activity and cellular thickness of human mesenchymal stem cells. Biochem Biophys Res Commun 368:256-260.
43. Nakagami H, K Maeda, R Morishita, S Iguchi, T Nishikawa, Y Takami, Y Kikuchi, Y Saito, K Tamai, T Ogihara and Y Kaneda. (2005). Novel autologous cell therapy in ischemic limb disease through growth factor secretion by cultured adipose tissue- derived stromal cells. Arterioscler Thromb Vasc Biol 25:2542-2547.
44. Wagers AJ, RI Sherwood, JL Christensen and IL Weissman. (2002). Little evidence for developmental plasticity of adult hematopoietic stem cells. Science 297:2256-2259.
45. Ziegelhoeffer T, B Fernandez, S Kostin, M Heil, R Voswinckel, A Helisch and W Schaper. (2004). Bone marrow-derived cells do not incorporate into the adult growing vasculature. Circ Res 94:230-238.
46. Rehman J, D Traktuev, J Li, S Merfeld-Clauss, CJ Temm-Grove, JE Bovenkerk, CL Pell, BH Johnstone, RV Considine and KL March. (2004). Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation 109:1292-1298.
47. Miranville A, C Heeschen, C Sengenes, CA Curat, R Busse and A Bouloumie. (2004). Improvement of postnatal neovascular- ization by human adipose tissue-derived stem cells. Circulation 110:349-355.
48. Planat-Benard V, JS Silvestre, B Cousin, M Andre, M Nibbelink, R Tamarat, M Clergue, C Manneville, C Saillan-Barreau, M Duriez, A Tedgui, B Levy, L Penicaud and L Casteilla. (2004). Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives. Circulation 109:656-663.
49. Kilroy GE, SJ Foster, X Wu, J Ruiz, S Sherwood, A Heifetz, JW Ludlow, DM Stricker, S Potiny, P Green, YD Halvorsen, B Cheatham, RW Storms and JM Gimble. (2007). Cytokine profile of human adipose-derived stem cells: expression of angiogenic, hematopoietic, and pro-inflammatory factors. J Cell Physiol 212:702-709.